Peptide lip products: balms, glosses and volumising claims

A peptide lip product is a cosmetic containing one or more peptide ingredients. It may simultaneously contain oils, waxes, humectants, occlusive agents, hyaluronic acid, pigments, flavours, fragrances and other ingredients that affect softness, shine, colour, hydration, surface texture or the appearance of fuller lips.

Therefore, a peptide is just one element of the whole formulation. The word „peptide” on its own on the label does not indicate which ingredient is responsible for the visible or measurable change.

This distinction is particularly important when evaluating claims regarding lip augmentation.

Smoother surface, higher gloss, more distinct vermilion border, transient swelling, the impression of fuller lips, increased lip height, greater projection and measured three-dimensional volume are different outcomes. The product may affect one of them without inducing the others.

Similarly, the temporary change observed during the use of the cosmetic is not evidence of permanent tissue growth.

The research discussed in this article includes a directly relevant study on a lip preparation containing peptides and hyaluronic acid, as well as separate studies on topical lip products, hydration, tolerance, and ingredient hypersensitivity. [4] [6–9]

The available data therefore makes it possible to discuss specific formulations and certain results. However, they do not prove that every peptide lip balm, gloss, tint, serum, mask or plumping product gives the same effect.

What is a peptide lip product?

Comprehensive formulation containing a peptide ingredient

Peptides are molecules built from amino acid residues linked by peptide bonds. Peptides used in cosmetics can differ significantly in their amino acid sequence, molecule size, charge, chemical modifications, solubility, stability, and proposed biological function.

A formulation containing one precisely defined peptide is therefore not equivalent to a product containing another peptide or an unspecified mixture of peptide fragments.

The word „treatment” or its equivalents are frequently used in the names of cosmetics. However, such a description on its own does not confirm any medical or therapeutic action.

A lip product can primarily serve a moisturising, occlusive, glossing, colouring, or conditioning function, or combine several of these functions. Therefore, its performance should be evaluated in accordance with the specific claim rather than on the basis of the product name alone.

The finished formulation can combine ingredients serving many different roles. Humectants interact with water, emollients improve softness and slip, and occlusive substances can limit water loss from the surface. Pigments change colour, whereas film-forming ingredients can influence gloss and smoothness.

Peptides may be added due to their proposed biological function, but this does not eliminate the importance of the other formulation components.

A similar rule applies in the case of creams and peptide moisturisers, where the effect of the finished product can also result from both the properties of the base and the peptide ingredients.

Research on moisturisers indicates both a direct effect of formulation ingredients on skin properties and the role of the vehicle as a carrier for additional substances. [1]

Therefore, smoother or softer lips after application are not automatically proof of peptide-induced signalling. A significant part of the immediate change may result from the properties of the formulation as a whole.

Determining the additional contribution of the peptide requires a study design that allows its effect to be separated from the action of the other ingredients.

The site of application is part of the research question

The visible, coloured part of the lips is referred to as the vermilion border. It should not be automatically treated as the equivalent of the skin surrounding the lips, the skin above the upper lip, the oral mucosa, or any other area of the face.

This matters when transferring the results of one cosmetic study to another application area.

Testing a peptide cream on facial skin may provide scientific justification for further study of a similar peptide in a lip product. However, it does not prove on its own that the peptide behaves identically on the lips, has the same penetration properties, produces the same visual effect or features the same tolerance profile.

A controlled study of palmitoyl pentapeptide on the face evaluated a specific moisturising formulation and changes regarding fine lines and wrinkles. [2] It did not evaluate lip volume.

The lip claim therefore becomes significantly more informative when the actual product is tested directly on the lips and the measurement used corresponds to the claimed effect.

In research, a distinction must be made between lip moisturisation, surface structure, definition of the lip border, gloss, perceived fullness, lip height, projection, three-dimensional volume, and perioral wrinkles.

These are not equivalent endpoints.

The name of the peptide does not confirm its delivery or tissue remodelling

Identifying a peptide in a product's formulation is merely the beginning of the chain of evidence.

The proposed mechanism of action of the ingredient is not the same as the confirmed effect of the finished cosmetic product.

If, for example, a peptide affects fibroblasts in cell culture, it does not automatically mean that ordinary topical application of a lotion delivers the same molecule to the relevant cells in a sufficient concentration.

The individual stages must therefore be considered separately:

peptide identity → its quantity → stability in the formulation → delivery to the appropriate tissue → biological interaction → visible or measurable clinical effect.

Evidence for one stage does not automatically confirm subsequent ones.

Analytical investigations of palmitoyl peptides in cosmetic matrices show that the peptide content can be measured using appropriate methods. [3] This is valuable information, but detecting the peptide in the product does not mean it is delivered to living tissue.

Similarly, the delivery of a peptide to the tissue is not equivalent to a clinically significant increase in lip volume, and visible plumpness does not constitute proof of new collagen formation or permanent tissue growth.

Terms such as „encapsulated”, „liposomal”, „vesicular” or „advanced delivery system” also describe formulation solutions. If they are intended to suggest better penetration or greater biological activity, they require appropriate evidence.

Peptide concentration is not a universal scale of efficacy

A higher declared percentage of peptide does not automatically mean a stronger effect from the lip product.

Individual peptides differ in sequence, structure, molecular properties and proposed biological functions. Additionally, the given percentage may refer to the finished raw material complex rather than the pure peptide.

Such a complex may contain a peptide along with water, glycerine, solvents, stabilisers, preservatives or other excipients.

Therefore, „5% of the peptide complex” does not necessarily mean that 5% of the entire cosmetic product is pure peptide.

Even when the amount of pure peptide is known, concentration alone does not determine efficacy. The vehicle, stability, exposure time, delivery to the appropriate site, and the actually measured effect also matter.

Lip balms, lip glosses, tints, lip serums and lip masks

The individual formats partially overlap

Lip balm is usually associated with care, comfort, moisturisation and protection of the lip surface. Lip gloss focuses primarily on shine and finish, a lip tint adds colour, a serum usually has a lighter texture, and a lip mask can be designed to stay on the surface for a longer time.

However, these categories overlap.

A single product can simultaneously be a balm, a colouring and glossing product, contain peptides and be advertised as a cosmetic that gives the effect of fuller lips.

Adding the peptide does not remove the fundamental formulation differences and does not automatically make one format more effective than the other.

Two peptide balms can contain completely different peptides and moisturising systems. A tinted lip gloss can share many ingredients with a balm, but differ in pigments, film-forming substances, flavourings, or consistency.

Names help describe the type of cosmetic being sold, but they do not replace information about its ingredients and tests of the specific product.

Gloss and colour can affect the impression of fuller lips

The glossy surface changes the way light is reflected. The pigment can alter the contrast, and a more defined lip line can affect the perception of shape.

As a result, the lips may look smoother, more defined, symmetrical or fuller.

These are real cosmetic effects, but they should not automatically be regarded as a measurement of anatomical volume.

This is of particular importance when interpreting „before and after” photographs. A photograph taken without the product and a photograph of lips covered with a glossy layer can look distinctly different even without structural enlargement.

Lighting, camera angle, focal distance, mouth placement, facial expression, head position, and image processing may also be significant.

In the peptide-hyaluronic acid formulation study, gloss, surface texture, and vermilion border definition were evaluated as separate outcomes. [4]

That is an important distinction. The improvement in gloss should remain a gloss outcome rather than being presented as evidence of new tissue formation.

Standardisation of photography matters

Before-and-after product photographs can be useful, but their scientific value depends on standardisation.

In a properly designed study, it is worth controlling the camera position, distance, lighting, facial expressions, mouth positioning, head position, time since product application, and whether the cosmetic is still on the lips when the photograph is taken.

If a photograph taken after the application of the product shows a glossy layer that was not present in the initial photo, part of the difference may be due to the cosmetic finish itself.

Similarly subtle changes in the positioning of the lips can influence their apparent projection or height.

Standardised three-dimensional imaging can limit some of the problems of conventional photography, but it still requires repeatable positioning and clearly defined anatomical boundaries.

Colour and peptide content answer different questions

The colour performance of the tint relates to coverage, shade, intensity, longevity and visual effect. The peptide claims, on the other hand, relate to a different part of the formulation.

An attractive colour does not confirm collagen-related efficacy. Similarly, testing a colourless formulation does not automatically mean an identical cosmetic profile or tolerance for each colouring variant.

Pigments can affect the composition of the formulation, and different shades may contain other colourings or additional ingredients.

The presence of pigment does not mean the product is unsuitable, just as the absence of pigment does not guarantee good tolerance. What matters is the full formulation.

The packaging does not specify the concentration

The stick, tube, jar, pump or applicator does not indicate the peptide concentration.

Packaging can affect dosage, ease of use, risk of contamination, exposure to oxygen and product protection. However, it does not constitute a measure of peptide activity.

Similarly, the percentage given alongside the name of the peptide complex should be interpreted according to what it actually refers to.

Analytical peptide testing in cosmetic matrices shows why actual content must be measured rather than inferred from how a product is presented. [3]

Even a reliable measurement of content remains, however, something other than confirmation of clinical efficacy.

Hydration and lip-plumping claims

„The ”magnification effect" requires a precise definition

The term „plumping” can refer to a wide variety of cosmetic effects.

It can mean reduced visibility of dryness, a smoother surface, greater gloss, temporary swelling, perceived fullness, increased lip height, greater projection, a change in dimensions, or an increase in measured three-dimensional volume.

These concepts should not be treated as synonyms.

A scientifically useful statement should specify what exactly has changed, how it was measured, how large the change was, what it was compared against, and how long it lasted.

The statement „participants rated their lips as fuller” describes a perceptual outcome. „The vertical height of the lip increased” denotes a dimensional outcome. „The three-dimensional lip volume increased,” on the other hand, is a geometric outcome.

The claim that „new collagen caused permanent enlargement” is a much more far-reaching structural and mechanistic declaration, which requires correspondingly stronger evidence.

Such an approach does not negate transient cosmetic effects. It simply allows them to be described in accordance with actual evidence.

Hydration can change appearance without permanent enlargement

Dry lips can be rough, flaky, have more pronounced surface lines and an irregular texture.

A formulation that improves surface hydration and condition can make the lips look smoother and more even. This can also alter the perception of their fullness.

However, this does not automatically mean the formation of new collagen, elastin, new tissue, or a permanent anatomical enlargement.

In a separate, open-label study, a two-step hyaluronic acid lip preparation was evaluated in 36 women over four weeks. [6] Clinical condition, hydration, and fullness-related parameters measured with a digital calliper were assessed, among other things.

An improvement compared to the initial values was noted, but it was not a study of the peptide itself. An open-label design based on a comparison with the baseline also did not allow for determining which component was responsible for the individual changes.

A change in dimension does not always mean a change in volume

Lip geometry can be measured in several ways. Vertical height, horizontal width, projection, surface area and three-dimensional volume describe different properties.

A digital caliper can show a change in a specific distance. It should not automatically be presented as a change in total 3D volume.

On the other hand, three-dimensional imaging can estimate volume change, but still does not indicate the biological cause of this change.

A reliable description should therefore retain the original parameter used in the study, rather than turning every geometric result into the statement „volume increased”.

Increased blood flow and irritation are not proof of peptide-induced remodelling

Some lip-plumping products contain ingredients that affect local blood circulation or sensory perception.

They can alter redness, warmth, swelling, tingling and the sensation of fullness independently of peptide-related mechanisms.

The full text of the peptide-hyaluronate formulation study indicated the presence of benzyl nicotinate, an ingredient that induces local hyperaemia. In the first cohort, an increase in erythema was also observed during active use. [4]

This creates a significant problem with attribution of effect.

If redness or a local vascular reaction appears during the use of the product, while at the same time the lips appear fuller, the entire change cannot automatically be attributed to tissue remodelling induced by the peptide.

Similarly, tingling is not proof of a peptide's effectiveness. The sensory sensation does not confirm collagen production, elastin production, peptide penetration, or structural enlargement.

Swelling and structural enlargement are not the same thing

Transitional swelling can increase the visible or measurable dimensions of the lips. However, this does not mean the formation of new structural tissue.

The declaration regarding tissue remodelling requires evidence appropriate for such a process.

This is particularly important when the product causes redness, warmth, tingling or irritation. The temporary increase in size associated with such reactions should not automatically be described as lip growth resulting from collagen production.

Therefore, the most important questions are: what has changed, why is it believed that this change occurred, and how long did the effect last?

The durability of the effect must be assessed after stopping use.

A study conducted during active product use shows what happens during exposure to the formulation. It does not automatically indicate which effects persist after discontinuation.

Declaration of permanent or lasting enlargement requires appropriate observation after discontinuation of use.

In the study of the peptide-hyaluronic preparation, after three weeks of use, a two-week product-free period was applied. [4]

The authors described that the observed changes returned or almost returned towards the initial values.

This has major interpretive significance and argues against presenting this study as evidence of permanent lip augmentation.

However, this does not mean that every peptide balm works for the exact same length of time. The result pertains to a specific formulation, participants, duration of use, and measurements applied.

Evidence regarding ready-to-use formulations

What exactly was investigated in the publication regarding the peptide lip product?

A 2025 publication evaluated a multi-ingredient oral formulation containing peptides, hyaluronic acid and other functional ingredients. [4]

The publication included two small single-centre studies, additional practice examples and a set of three-dimensional measurements.

These elements should not be combined in a way that suggests they formed a single large controlled study.

The initial study involved 18 participants who had never previously received lip fillers or had not received them within the preceding 12 months.

The second study included 11 participants who had previously undergone lip augmentation with hyaluronic acid. Nine individuals received the study formulation and two received placebo.

The authors themselves pointed out that the placebo group was too small to carry out a reliable statistical comparison of the treatment with placebo.

Participants also had access to an additional lip-conditioning product.

The trial formulation contained several ingredients that could affect hydration, surface finish, redness and local appearance. Therefore, neither the study design nor the product composition allowed for the effect of the peptides alone to be isolated.

The authors described favourable aesthetic outcomes, but the design limitations significantly affect the strength and scope of the possible conclusions.

„Placebo-controlled” does not always mean an informative comparison with a placebo

The study may formally include a placebo group, but this group may be too small to allow a meaningful comparison.

This was the case in the second study, where only two people received a placebo. [4]

Therefore, the mere presence of placebo participants should not be treated as evidence of the same strength as in a sufficiently large, randomised, placebo-controlled trial.

When evaluating the study, it is worth checking the number of participants in each group, randomisation, blinding, comparator matching, the feasibility of statistical comparison, and whether the sample size was adequate for the analysed outcome.

The study design label is useful, but concrete figures remain crucial.

Examples of volume changes are not a controlled result of the whole group

The publication presents additional clinical cases evaluated using three-dimensional imaging and examples of changes in lip volume and dimensions. [4]

These observations are relevant and it would not be correct to claim that the publication did not contain any geometric or volumetric measurements.

However, these examples were separated from the main cohorts and did not constitute an adequate controlled dataset to estimate the average causal effect of the formulation.

Selected cases do not make it possible to determine how often the effect occurs, what its average magnitude is, what change would have occurred without the product, nor which ingredient is responsible for the result.

The precise number still depends on the quality of the study design

A three-dimensional scanner can provide very precisely appearing numerical values. However, this does not automatically mean that the examination establishes the cause of the change.

Measurement quality and experiment design answer different questions.

The advanced device can accurately detect the geometrical change. To determine why it occurred, an appropriate comparator and the correct study design are still required.

Lip measurements can be affected by, among other things, head position, facial expressions, lip posture, the choice of anatomical landmarks, the method used to define the vermilion border, the time elapsed since application, and the reproducibility of the imaging procedure.

An objective number can increase the reliability of a measurement, but it does not replace experimental control.

Tolerance data from the full text changes the interpretation

The study abstract stated that no adverse events were reported.

However, the full text also reports increased dryness in the first week in the first cohort, and increased erythema during several visits in the active treatment period. [4]

This information does not have to be contradictory. The study may classify formally recorded adverse events separately from local symptoms evaluated by the investigator.

That is why the result should not be simplified to the statement „no irritation occurred”.

A more detailed description should indicate which symptoms were assessed, which changed, when they occurred, and how the authors classified them.

The small number of participants further limits the ability to assess rare reactions.

Funding and conflicts of interest should be assessed together with the methodology

The study was commercially funded, and the publication discloses links between some of the authors and the company. [4]

Commercial funding does not automatically mean that a study is unreliable. Similarly, independent funding does not guarantee high methodological quality.

Funding information should be analysed together with randomisation, blinding, sample size, comparator quality, outcome selection, statistical analysis, reporting transparency and independent replication.

In this case, small trials and a very limited comparison with placebo alone justify a cautious interpretation.

Independent replication of the results would increase the level of confidence.

The study does not confirm equivalence with injectable fillers

Although the authors discuss the topical formulation in the context of injection procedures, no direct comparative study has been conducted to confirm equivalence in terms of volume, effect size, durability, predictability, or clinical performance.

The presence of hyaluronic acid in both a topical product and a filler does not make them equivalent interventions.

The route and site of exposure are fundamentally different. A substance applied to the surface of the mouth is not automatically comparable to material introduced directly into the tissue.

People who have previously received fillers also constitute a distinct population.

The improvement in appearance in individuals who have previously undergone lip augmentation does not prove that a topical product recreates the effect of a filler, prolongs its action, or can replace an injection procedure.

To answer these questions, research specifically designed for this purpose would be required.

Other lip product research addresses narrower questions

The two-stage study of the hyaluronic acid preparation is another example of short-term evaluation of the entire formulation. [6] Its open-label design limits the possibility of establishing a causal relationship.

A separate publication regarding the prototype lotion described three studies analysing irritation, sensitisation, photosensitivity reactions, acceptability, and 28-day use in subjects described as having sensitive skin. [7]

This study shows how the tolerance of a specific balm can be evaluated. However, it does not provide proof that every peptide lip product is safe, that every person with sensitive skin will tolerate such a cosmetic well, or that peptides cause lip enhancement.

These examples demonstrate the fundamental principle: different research projects answer different questions.

Tolerance testing supports tolerance conclusions. Hydration testing supports hydration conclusions. Dimensional testing supports dimensional conclusions, and a mechanistic experiment can support a mechanistic hypothesis.

They should not be combined into a claim broader than the available evidence.

Irritation and hypersensitivity to ingredients

Irritation and allergy are different phenomena

Irritation and allergic contact dermatitis are not the same process.

Irritation can result from the direct local action of a substance and does not require the same immunological mechanism as an allergy. Allergic contact dermatitis, on the other hand, is associated with an immune response to a substance to which the individual has previously been sensitized.

However, the symptoms may partially overlap.

Within the mouth area, redness, flaking, dryness, burning, itching, swelling, cracking or discomfort may appear.

Looks alone do not always allow you to determine the cause.

A reaction after applying a product containing a peptide does not prove that the peptide is responsible for it. Potential factors may also include fragrances, flavours, preservatives, waxes, plant ingredients, pigments and other formulation elements.

Symptoms around the mouth can also have causes unrelated to the cosmetic product.

Cheilitis research should not be turned into general risk data

A large retrospective study evaluated allergen sensitisation in patients with cheilitis referred for patch testing. [8]

This confirms the importance of contact allergy in the clinical population in whom the problem was already suspected.

However, it does not determine the probability of developing an allergy in an average person using the peptide balm.

The population of individuals referred for testing is not representative of the general population. Therefore, data from clinical allergy studies should not be converted into a general percentage risk for cosmetics users.

„Natural” does not mean „hypoallergenic”

Ingredients of natural origin can also cause allergic reactions in susceptible individuals.

Reactions to beeswax and propolis were analysed in a study involving 95 selected patients with cheilitis, facial eczema, or suspected beeswax allergy. [9]

Positive results were obtained in some of the participants.

This does not mean that beeswax is unsuitable for everyone, as the majority of users will react [fine], nor that natural waxes should be avoided across the board.

The conclusion is much narrower:

natural origin ≠ no possibility of an allergy occurring.

The complete ingredients list of a product is of greater importance than reassuring marketing terms.

Claims regarding sensitive skin should be backed by actual testing.

The terms „for sensitive lips” or „for sensitive skin” do not state who participated in the study, how many people were tested, what was measured, how long the observation lasted, or what was considered a reaction.

Information on a specific tolerance study is more useful.

The publication regarding the prototype lotion included several compatibility evaluations and a specified period of product use. [7]

These results relate to the tested prototype and the experimental conditions, and not to all peptide-containing oral products.

Similarly, the proposed safety assessment models for cosmetic peptides can help researchers organise safety questions. [10] However, a theoretical or computational model does not replace tolerance data for the finished product.

„Dermatologically tested” on its own does not describe the result

The information that a product has been dermatologically tested has limited value without a description of the testing method.

It is worth knowing how many people participated, whether people with sensitive skin were selected, how long the product was used, whether the lip area specifically was evaluated, what reactions were recorded, whether a control group was used, and whether anyone stopped participating due to symptoms.

The mere fact of specialist supervision does not replace information about the design and results of the study.

A symptom is not a measure of effectiveness

Burning, persistent itching, painful swelling or increasing redness should not be presented as proof that the peptide is „working”.

Feelings do not measure collagen production, peptide delivery, tissue remodelling or beneficial structural enlargement.

Persistent or recurring symptoms around the mouth may require evaluation rather than repeatedly attributing them to a cosmetic plumping effect.

If contact allergy is suspected, a specialist may use appropriately selected patch tests. This is different from applying a small amount of a cosmetic product at home yourself.

Research on cheilitis shows why identifying the relevant factor may require analysing specific ingredients rather than focusing solely on the marketing-highlighted peptide. [8]

How to evaluate evidence regarding peptide lip-plumping products?

A practical way is to trace the entire chain of evidence.

1. Determine precisely which peptide is in the product

The term „peptide complex” provides less information than a chemically defined peptide.

2. Check the full formulation ingredients

It is worth establishing whether the product also contains ingredients that may affect hydration, redness, swelling, gloss or surface texture.

3. Define the declared effect

Does „plumping” mean smoother lips, a fuller look, greater height, greater projection, or measured volume?

4. Check the comparator

Was the result compared with the baseline state, placebo, a suitable vehicle, another product, or was no comparison used?

5. Check the measurement method

Was the result based on subjective assessment, standardised photographs, calliper measurements, moisture measurement or validated 3D imaging?

6. Check whether the product remained on the lips during the measurement

The glossy layer can alter its appearance, which is important when interpreting photographs and certain surface assessments.

7. Check the duration of the effect

Was the result measured immediately, after a few days, after a few weeks, or also after discontinuing the product?

8. Separate fullness from irritation

Redness and swelling can affect appearance without confirming structural tissue remodelling.

9. Check whether the effect of the peptide has indeed been isolated

Testing a multi-ingredient product primarily provides information on the entire formulation, unless the design allows the effect of the peptide to be isolated.

10. Check the funding and independent verification of results

Commercial funding does not invalidate a study, but robust controls and independent replication of results increase confidence in the conclusions.

Frequently asked questions

1. Do peptide balms increase lip volume?

The mere presence of the peptide does not confirm an increase in volume. A publication directly related to the peptide-hyaluronic formulation described an improvement in appearance and separate examples of three-dimensional measurements, but the very small placebo group made a reliable comparison of the treatment with placebo impossible. [4] The test product also contained several other functional ingredients, so it could not be determined that the observed changes were solely due to the peptides. Some formulations may affect perceived fullness or specific dimensions, but available data do not confirm a universal or lasting increase in volume by peptide balms as a whole category.

2. Are all peptide lip products equivalent?

No. They can differ in peptide sequence and concentration, chemical modifications, base, content of humectants, waxes, oils, hyaluronic acid, pigments, fragrances, flavourings and other ingredients. A publication directly related to the topic concerned a complex formulation, rather than peptides as a uniform category. [4] Therefore, the results of one product should not be automatically transferred to another balm, lip gloss, tint, serum or mask. The full composition and appropriate product testing provide much more information than the name „peptide” alone.

3. Is the peptide lip gloss stronger than the peptide lip balm?

Not necessarily. The terms „lip gloss” and „balm” primarily describe the format, consistency, finish and cosmetic purpose. They do not define the standard concentration of the peptide, its delivery method or biological activity. A glossy formulation can make the lips look smoother or fuller due to the way it reflects light, without a higher peptide content or a stronger structural effect. Analytical methods make it possible to measure the peptide content in cosmetics, but content alone does not determine clinical efficacy. [3]

4. Does the peptide tint have the same evidence as its clear version?

Not automatically. The colouring version may differ in pigments and other formulation elements. Colour and contrast can also alter the perception of the lip contour and fullness. Separate evaluation of gloss, surface structure and the vermilion border in the study of the peptide product shows why these features should be treated as distinct outcomes. [4] Testing one version of a product most directly supports that very version. Transferring results to another shade or variant requires adequate comparability of the formulations.

5. Do smoother lips mean the generation of new collagen?

No. A smoother surface may result from hydration, the action of emollients, occlusion or the formation of a more uniform cosmetic layer. Studies on moisturising preparations show that the formulation itself can alter the appearance and feel of the skin without deeper structural remodelling. [1] Collagen production is a separate mechanistic claim requiring appropriate evidence. If a study measured only smoothness, the result should be described as an improvement in smoothness, and not automatically as collagen synthesis.

6. Are lip hydration and lip volume the same parameter?

No. Hydration and volume describe different properties and require different measurement methods. The hydration measurement device assesses water-related properties, whereas dimensional or three-dimensional measurements deal with geometry. In the study of the two-step hyaluronic acid product, both hydration measurements and calliper measurements were used, which demonstrates that these are distinct endpoints. [6] Improved hydration may influence the appearance of the lips, but it should not be presented as a measured increase in volume if volume was not actually assessed.

7. Does the tingling mean that the peptide lip product is working?

No. Tingling is a sensory reaction, not a validated measurement of peptide activity. Some lip products contain ingredients that affect local sensations, redness or blood flow independently of peptides. In the study of the peptide-hyaluronic preparation, there was an ingredient inducing local hyperaemia, and changes in erythema were observed during active use. [4] This does not constitute proof of peptide-induced tissue remodelling. Efficacy should be assessed on the basis of an appropriate measurement of the claimed effect, rather than the intensity of sensations following application.

8. Do temporarily fuller lips mean permanent enlargement?

No. A fuller appearance while using the product does not confirm permanent tissue growth. Appearance can be influenced by hydration, gloss, redness, swelling and surface smoothing. In the study of the peptide product, a two-week washout period was used, during which the observed effects returned or nearly returned towards baseline values. [4] This argues against interpreting this particular study as evidence of permanent enlargement. Claims of permanent structural change require appropriate measurements after discontinuation of product use.

9. Can a peptide lip product be considered the equivalent of a filler?

Available data do not confirm such equivalence. The study of the peptide formulation did not include an adequately designed direct comparison with a filler that would demonstrate equivalent volume, effect size, predictability or durability. [4] Topically applied hyaluronic acid and hyaluronic acid introduced into tissue via injection imply fundamentally different exposure conditions. The similarity of the ingredient, favourable photographs or a satisfaction rating do not replace a comparative study designed to demonstrate equivalence.

10. Can the results obtained in individuals with prior lip augmentation be directly transferred to those without fillers?

Not necessarily. Prior augmentation can affect the baseline anatomy, appearance and interpretation of subsequent changes. In a publication concerning a peptide product, individuals with prior augmentation were analysed separately, but the group included only nine people using the product and two receiving placebo. [4] Such a small control group does not allow for a robust estimation of the product's superiority over placebo. Therefore, the results concerning previously augmented lips should remain specific to this population.

11. Does the 3D photograph prove that peptides are responsible for the change in volume?

No. Three-dimensional imaging can provide valuable geometric measurements, but it does not indicate by itself which component caused the change. Interpretation still depends on position standardisation, measurement repeatability, definition of anatomical boundaries, the timing of the scan and the appropriate comparator. Additional 3D examples in the publication concerning the peptide product did not constitute a controlled estimation of the effect of the peptides themselves. [4] An objective method can improve measurement quality, but establishing the cause requires an appropriate experimental design.

12. Does „no adverse reactions” mean that no irritation occurred?

Not necessarily. The study may separately classify formally reported adverse events and local symptoms assessed by the investigator. A publication concerning the peptide preparation reported no adverse events while simultaneously describing increased erythema and early-onset dryness in one of the cohorts. [4] This information may coexist due to the method of classification. Therefore, simplifying this to the statement „the product did not cause irritation” would omit part of the results.

13. Can a natural ingredient in a lip product cause contact allergy?

Yes. Natural origin does not exclude the possibility of an allergic reaction in a susceptible individual. In a study of selected patients with cheilitis, facial eczema, or suspected beeswax allergy, some participants showed positive reactions to beeswax or propolis. [9] Because this was a selected clinical population, the results should not be used to estimate risk in the general population. However, they show that „natural” describes the origin of an ingredient, not a guarantee of its tolerability.

14. Does a reaction to a peptide balm mean an allergy to peptides?

No. A reaction to the finished product does not automatically identify the responsible ingredient. Fragrances, flavourings, preservatives, waxes, pigments, plant-based ingredients or other formulation components may be significant. Nor is every reaction allergic. Studies of individuals referred for patch testing due to cheilitis show why the analysis of specific allergens is sometimes necessary. [8] The cause of an individual reaction cannot be determined from the product name alone.

15. Does the designation „for sensitive lips” guarantee no reaction?

No. Such a term does not guarantee universal tolerance. More information is provided by the description of the participants, the duration of the study, the methods used and the observed reactions. The publication concerning the prototype balm evaluated a single formulation in several compatibility tests, including during a specific period of use by individuals described as having sensitive skin. [7] The results refer to this specific product and conditions, and not to all peptide lip cosmetics.

16. Can testing a peptide in a facial cream confirm the effect of lip augmentation?

Not directly. Facial wrinkles and lip volume involve different anatomical areas and different endpoints. A controlled study of palmitoyl pentapeptide on the face evaluated fine lines and wrinkles associated with a specific moisturising formulation, rather than anatomical lip enhancement. [2] Such a study can provide information about the peptide and justify further experiments, but it does not independently confirm a volumising effect in a different product and at a different site of application.

17. What would stronger evidence for a peptide lip product look like?

Stronger evidence would comprise an adequately sized, randomised and preferably blinded controlled trial of the finished formulation, with pre-specified oral endpoints and reproducible measurement methods. If the claim relates to volume, validated 3D imaging would be more informative than selected photographs. In the case of claims regarding sustained enhancement, follow-up after discontinuation would also be needed. A control formulation differing solely in the presence of the peptide would help to establish its incremental contribution. The current study leaves these issues unresolved due to the small control group and multi-ingredient product. [4]

18. Does a higher percentage of the peptide mean a stronger lip enhancement?

No. The peptide percentage is not a universal scale for enlarging action. Individual peptides have different structures and proposed functions, and the given value may refer to the entire raw material complex rather than the pure peptide. Formulation, stability, delivery and exposure time are also important. Chemical analysis can determine the amount of peptide in a cosmetic, but even an accurate measurement is not proof of lip volumisation. [3] What is more important is whether a specific formulation at a given concentration has actually produced the declared effect in a properly designed study.

19. Can redness make the lips look fuller?

Yes. Changes in local redness or vascular response can affect the appearance of the lips and may occur together with transient swelling. This is one of the reasons why fullness should not automatically be attributed to structural remodelling. Benzyl nicotinate was present in the peptide-hyaluronate formulation under investigation, and changes in erythema were observed during use. [4] This does not prove that the redness was responsible for all the observed effects, but it provides an alternative explanation that should be taken into account.

20. Does an increased lip height mean a larger total lip volume?

Not necessarily. The height of a lip is a single geometric dimension, whilst volume is a three-dimensional property. An increase in vertical height may occur without a proportional increase in total volume. A digital calliper, a two-dimensional photograph and three-dimensional imaging therefore answer different questions. [6] When reporting the result, the original end point must be retained. If an increase in height has been measured, it should be described as an increase in height, unless an independent volume measurement also confirms a change in total volume.

21. Does the peptide lip product permanently build new tissue?

Available data do not confirm a permanent increase in tissue following topical application of peptide lip products. In a directly related study of a peptide-hyaluronic acid formulation, changes were observed during active use, but in the post-discontinuation period the results returned or almost returned towards baseline values. [4] Permanent structural enlargement would require significantly stronger evidence, including appropriate biological measurements and longer follow-up after the end of use. Short-term improvements in hydration, gloss, texture or dimensions should therefore not be presented as the permanent creation of new tissue.

22. Is a „before and after” photograph sufficient to confirm the effect of lip augmentation?

No. Photographs can document appearance, but they are susceptible to variations in lighting, camera position, facial expression, mouth positioning, product sheen, colour and image manipulation. A standardised photographic protocol can limit some of these issues, but it still does not directly measure anatomical volume. Three-dimensional imaging can provide additional geometric information, but establishing the cause of a change still requires appropriate control. [4] „Before and after” photographs are therefore most useful as a complement to measurements rather than a replacement for them.

Limitation of evidence

The evidence regarding peptide lip products has several important limitations.

Firstly, it is not a standardised category. Individual products may contain different peptides, concentrations, bases, humectants, waxes, pigments and sensory ingredients.

Secondly, most visible changes can have more than one explanation. A fuller appearance can result from hydration, surface smoothing, gloss, a better defined vermilion border, redness, transient swelling, a change in dimensions, or a combination of several of these factors.

Thirdly, the peptide-hyaluronic study directly related to the topic concerned a multi-ingredient formulation. [4] It therefore provides data primarily on the finished product rather than on the isolated effect of the peptides.

Fourthly, the placebo group was exceptionally small. Nine people using the product and two receiving placebo do not provide the same strength of evidence as a properly sized controlled trial. [4]

Fifthly, selected examples from 3D imaging do not determine the average effect in the entire user population.

Sixthly, de-challenge observations argue against interpreting the recorded changes as permanent enlargement. [4]

Seventhly, tolerance data must be treated with caution. The lack of formally reported adverse reactions does not mean that no local changes were observed, as erythema and early dryness have also been described. [4]

Eighthly, studies on peptides applied to the skin of the face cannot be independently used as evidence of lip augmentation, as both the site of application and the measured outcome differ. [2]

Ninthly, allergy testing in individuals referred on account of cheilitis should not be transformed into general data on the frequency of reactions in ordinary users of peptide products. [8] [9]

Ultimately, cosmetic appearance, dimensional measurements, tissue mechanisms and permanent structural changes represent different levels of evidence. They should remain separated until an appropriate study directly links them together.

Summary

Peptide lip products include balms, lip glosses, tints, serums, masks and other formulations containing one or more peptide ingredients.

However, the peptide is only part of the finished cosmetic product. Oils, waxes, humectants, hyaluronic acid, pigments, film-forming agents, ingredients that cause local hyperaemia, fragrances and other components can affect the appearance and feel of the lips.

This is of particular importance when evaluating claims regarding „plumping”.

A fuller lip appearance can result from hydration, surface smoothing, higher gloss, a more defined lip line, localized redness, temporary swelling, or measurable geometric changes.

These results should not automatically be described as permanent structural enlargement.

A directly relevant 2025 study on the peptide-hyaluronate formulation provides useful observations regarding appearance, dimensions, post-withdrawal period, and tolerance. [4]

Badanie obejmowało jednak niewielkie kohorty, bardzo małą grupę placebo, formulację wieloskładnikową oraz dodatkowe przykłady z praktyki, które nie stanowiły solidnego kontrolowanego porównania.

Dane nie pozwalają więc stwierdzić, że za obserwowane zmiany odpowiadały same peptydy. Nie potwierdzają również, że każdy balsam, błyszczyk czy tint z peptydami zwiększa objętość ust.

Szczególnie ważne są następujące rozróżnienia:

produkt zawierający peptyd ≠ efekt wywołany konkretnie przez peptyd;

połysk ≠ anatomiczna objętość;

nawilżenie ≠ trwałe powiększenie;

wysokość wargi ≠ całkowita objętość trójwymiarowa;

mrowienie ≠ skuteczność peptydu;

zaczerwienienie lub obrzęk ≠ strukturalna przebudowa;

pomiar trójwymiarowy ≠ dowód mechanizmu;

miejscowy kwas hialuronowy ≠ wypełniacz do wstrzykiwań;

and

tymczasowa poprawa ≠ trwały przyrost tkanki.

Najbardziej wiarygodna interpretacja pozostaje związana z konkretną formulacją, badaną populacją, komparatorem, sposobem pomiaru, czasem obserwacji i ograniczeniami projektu.

Disclaimer

Artykuł ma wyłącznie charakter edukacyjny i naukowo-informacyjny. Omawia peptydowe składniki kosmetyczne, formulacje produktów do ust, nawilżenie, efekty związane z wyglądem, pomiary geometryczne, tolerancję oraz opublikowane badania.

Nie stanowi porady medycznej ani dermatologicznej, diagnozy, zaleceń dotyczących leczenia ani rekomendacji zakupu lub stosowania konkretnego balsamu, błyszczyka, tintu, serum, produktu powiększającego usta, wypełniacza czy innego kosmetyku.

Wyników dotyczących jednego peptydu, formulacji, stężenia, populacji lub projektu badawczego nie należy automatycznie przenosić na inne produkty. Utrzymujący się obrzęk, ból, pieczenie, pękanie, nawracający stan zapalny ust lub podejrzenie reakcji alergicznej powinny zostać ocenione przez odpowiednio wykwalifikowanego specjalistę.

References

1. Draelos, Z. D. (2018). The science behind skin care: Moisturizers. Journal of Cosmetic Dermatology, 17(2), 138–144. https://doi.org/10.1111/jocd.12490
2. Robinson, L. R., Fitzgerald, N. C., Doughty, D. G., Dawes, N. C., Berge, C. A., & Bissett, D. L. (2005). Topical palmitoyl pentapeptide provides improvement in photoaged human facial skin. International Journal of Cosmetic Science, 27(3), 155–160. https://doi.org/10.1111/j.1467-2494.2005.00261.x
3. Chirita, R. I., Chaimbault, P., Archambault, J. C., Robert, I., & Elfakir, C. (2009). Development of a LC-MS/MS method to monitor palmitoyl peptides content in anti-wrinkle cosmetics. Analytica Chimica Acta, 641(1–2), 95–100. https://doi.org/10.1016/j.aca.2009.03.015
4. Moradi, A., Jacob, C., Tao, J., Love, R., Osborne, S., & Fleck, T. (2025). Efficacy and tolerability of a topical peptide-hyaluronic acid lip treatment using a novel delivery system in subjects with and without prior lip augmentation. Journal of Cosmetic Dermatology, 24(12), Article e70563. https://doi.org/10.1111/jocd.70563
5. U.S. Food and Drug Administration. (n.d.). Allergens in cosmetics. Retrieved September 20, 2026, from Allergens in cosmetics
6. Makino, E. T., Tan, P., Qian, K., Babcock, M., & Mehta, R. C. (2017). Clinical assessment of immediate and long-term effects of a two-step topical hyaluronic acid lip treatment. Journal of Drugs in Dermatology, 16(4), 366–371. https://pubmed.ncbi.nlm.nih.gov/28403271/
7. Nisbet, S. (2018). A prototype lip balm: Summary of three dermatological studies demonstrating safety and acceptability for sensitive skin. Journal of Cosmetic Science, 69(1), 1–8. https://pubmed.ncbi.nlm.nih.gov/29658873/
8. Silverberg, J. I., Chaubal, M., Warshaw, E. M., Maibach, H. I., Belsito, D. V., DeKoven, J. G., Zug, K. A., Taylor, J. S., Sasseville, D., DeLeo, V. A., Pratt, M. D., Reeder, M. J., Atwater, A. R., Fowler, J. F., Jr, & Houle, M. C. (2023). Prevalence and trend of allergen sensitization in patients with cheilitis referred for patch testing, North American Contact Dermatitis Group data, 2001-2018. Contact Dermatitis, 88(4), 300–314. https://doi.org/10.1111/cod.14265
9. Nyman, G. S. A., Tang, M., Inerot, A., Osmancevic, A., Malmberg, P., & Hagvall, L. (2019). Contact allergy to beeswax and propolis among patients with cheilitis or facial dermatitis. Contact Dermatitis, 81(2), 110–116. https://doi.org/10.1111/cod.13306
10. Bjerke, D. L., Li, J., Gao, Y., Hu, P., Lintner, K., & Hakozaki, T. (2026). A framework for the safety evaluation of peptides in cosmetics. Current Research in Toxicology, 10, Article 100291. https://doi.org/10.1016/j.crtox.2026.100291